Drug-associated blood cell dyscrasias

Compendium: Continuing Education For Veterinarians

Volumn 34, Issue 6, 2012, Pages

  Weiss, Douglas J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862603075     PISSN: 19408307     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Schalm OW. Phenylbutazone toxicity in two dogs. Canine Pract 1979;6:47-51.
2. Weiss DJ, Klausner JS. Drug-associated aplastic anemia in dogs: eight cases (1984-1988). J Am Vet Med Assoc 1990;196:472-475.
3. Jones RD, Baynes RE, Nimitz CT. Nonsteroidal anti-inflammatory drug toxicosis in dogs and cats: 240 cases (1989-1990). J Am Vet Med Assoc 1992;201:475-477.
4. Weiss DJ. Bone marrow necrosis in dogs: 34 cases (1996-2004). J Am Vet Med Assoc 2005;227:263-267. (Pubitemid 40993491)
5. Maddison JE, Page SW. Adverse drug reactions. In: Maddison J, Page S, Church D, eds. Small Animal Clinical Pharmacology. 2nd ed. New York, NY: WB Saunders; 2008:41-52.
6. Weiss DJ. Leukocyte response to toxic injury. Toxicol Pathol 1993;21:135-140. (Pubitemid 23241705)
7. Vincent PC. Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms. Drugs 1986;31:52-63.
8. Edwards CJ, Fuller J. Oxidative stress in erythrocytes. Comp Clin Pathol 1996;6:24-31. (Pubitemid 26241562)
9. Christian JA, Rebar AH, Boon GD, et al. Senescence of canine biotinylated erythrocytes: increased autologous immunoglobulin binding occurs on erythrocytes aged in vivo for 104 to 110 days. Blood 1993;82:3469-3473. (Pubitemid 23356721)
10. Weiss DJ, Greig B, Aird B, et al. Inflammatory disorders of bone marrow. Vet Clin Pathol 1992;21:79-84.
11. Bunch SE, Baldwin BH, Hornbuckle WE, et al. Compromised hepatic function in dogs treated with anticonvulsant drugs. J Am Vet Med Assoc 1985;184:444-449.
12. Weiss DJ, Smith SA. A retrospective study of 19 cases of canine myelofibrosis. J Vet Intern Med 2002;16:174-178. (Pubitemid 135746942)
13. Weiss DJ. A retrospective study of the incidence and the classification of bone marrow disorders in the dog at a veterinary teaching hospital (1996-2004). J Vet Intern Med 2006; 20:955-961. (Pubitemid 44338060)
14. Benichou C, Solal Celigny P. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting. Nouv Rev Fr Hematol 1991;33:257-262.
15. Couto CG. Toxicity of anticancer chemotherapy. In; Campfield WW, ed. Kal Kan Symposium for the Treatment of Small Animal Diseases. Vermon, CA: Kal Kan Pet Foods; 1986:37-45.
16. Barger AM, Grindem CB. Hematologic abnormalities associated with cancer therapy. In Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2000:676-681.
17. Alleman AR, Harvey JW. The morphologic effects of vincristine sulfate on canine bone marrow cells. Vet Clin Pathol 1993;22:36-41.
18. Weiss DJ, Aird B. Cytologic evaluation of primary and secondary myelodysplastic syndromes in the dog. Vet Clin Pathol 2002;30:67-75.
19. O'Keefe DA, Schaeffer DJ. Hematologic toxicosis associated with doxorubicin administration in cats. J Vet Intern Med 1992;6:276-282.
20. Harvey JW, French TW, Senior DF. Hematologic abnormalities associated with chronic acetaminophen administration in a dog. J Am Vet Med Assoc 1986;189:1334-1335. (Pubitemid 17211174)
21. Christiansen G. The toxicity of selected therapeutic agents used in cats. Vet Med 1980;75:1133-1141.
22. Sherding RG, Wilson GP, Kociba GJ. Bone marrow hypoplasia in eight dogs with Sertoli cell tumor. J Am Vet Med Assoc 1981;178:497-501.
23. Hoenig H. Six dogs with features compatible with myelonecrosis and myelofibrosis. J Am Anim Hosp Assoc 1989;25:335-339.
24. Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 4th ed. Philadelphia, PA: WB Saunders; 1995:1889.
25. Gaunt SD, Pierce KR. Effects of estradiol on hematopoietic and marrow adherent cells of dogs. Am J Vet Res 1986;47:906-909. (Pubitemid 16144208)
26. Farris GM, Benjamin SA. Inhibition of myelopoiesis by conditioned medium from cultured canine thymic cells exposed to estrogen. Am J Vet Res 1993;54:1366-1373.
27. Xavier FG, Kogika MM, Spinisa HS. Common causes of poisoning in dogs and cats in a Brazilian veterinary teaching hospital from 1998 to 2002. Vet Human Toxicol 2002;44:115-116. (Pubitemid 34242473)
28. Watson, ADJ, Wilson JT, Turner OM, et al. Phenylbutazone-induced blood dyscrasias suspected in 3 dogs. Vet Rec 1980;107:239-241. (Pubitemid 10026704)
29. Beale KM, Altman D, Clemmons RR, et al. Systemic toxicosis associated with azathioprine administration in domestic cats. Am J Vet Res 1992;53:1236-1240.
30. Rinkardt NE, Kruth SA. Azathioprine-induced bone marrow toxicity in four dogs. Can Vet J 1996;37:612-613. (Pubitemid 26366056)
31. Rodriguez DB, Mackin A, Easley R, et al. Relationship between red blood cell thiopurine methyltransferase activity and myelotoxicity in dogs receiving azathioprine. J Vet Intern Med 2004;18:339-345. (Pubitemid 38748354)
32. Trepanier LA. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. J Vet Pharmacol Ther 2004;27:129-138. (Pubitemid 38859446)
33. Giger U, Werner LL, Millichamp NJ, et al. Sulfadiazine-induced allergy in six Doberman pinschers. J Am Vet Med Assoc 1985;186:479-484. (Pubitemid 15146631)
34. Weiss DJ, Adams LG. Aplastic anemia associated with trimethoprim- sulfadiazine and fenbendazole administration in a dog. J Am Vet Med Assoc 1987;191:1119-1120. (Pubitemid 18082567)
35. Fox LE, Ford S, Alleman AR, et al. Aplastic anemia associated with trimethoprimsulfadiazine administration in two dogs. Vet Clin Pathol 1991;22:89-92.
36. Watson ADJ, Middleton DJ. Chloramphenicol toxicosis in cats. Am J Vet Res 1978;39:1199-1203. (Pubitemid 10206089)
37. Harvey JW, Wolfsheimer KJ, Simpson CF, et al. Pathologic sideroblasts and siderocytes associated with chloramphenicol therapy in a dog. Vet Clin Pathol 1994;14:36-42.
38. Deldar A, Lewis H, Bloom J, Weiss L. Cephalosporin-induced changes in the ultrastructure of canine bone marrow. Vet Pathol 1988;25:211-218.
39. Bloom JC, Theim PA, Sellers TS, et al. Cephalosporin-induced immune cytopenia in the dog: demonstration of erythrocyte-, neutrophil-, and platelet-associated IgG following treatment with cefazedone. Am J Hematol 1988;28:71-78.
40. Caprile KA. The cephalosporins antimicrobial agents: a comprehensive review. J Vet Pharmacol Ther 1988;11:1-32.
41. Blue JT, Dinsmore RP, Anderson KL. Immune-mediated hemolytic anemia induced by penicillin in horses. Cornell Vet 1987;77:263-276.
42. Helton KA, Nesbitt GH, Cariolo PL. Griseofulvin toxicity in cats: literature review and report of seven cases. J Am Anim Hosp Assoc 1986;22:453-458. (Pubitemid 16027555)
43. Rottman JB, English RV, Breitschwerdt EB, et al. Bone marrow hypoplasia in a cat treated with griseofulvin. J Am Vet Med Assoc 1991;198:429-431.
44. Shelly SM. Causes of canine pancytopenia. Compend Contin Educ Pract Vet 1988;10:9-16.
45. Weiss DJ, Evanson OA. A retrospective study of feline pancytopenia. Comp Clin Pathol 2000;10:50-55.
46. Peterson ME, Hurvitz AI, Leib MS. Propylthiouracil-associated hemolytic anemia, thrombocytopenia, and antinuclear antibody in cats with hyperthyroidism. J Am Vet Med Assoc 1984;184:806-808. (Pubitemid 14142942)
47. Peterson ME, Kintzer PP, Hurvitz AI. Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med 1988;2:150-157.
48. Jacobs G, Calvert C, Kaufman A. Neutropenia and thrombocytopenia in three dogs treated with anticonvulsants. J Am Vet Med Assoc 1998;212:681-684. (Pubitemid 28252255)
49. Thompson JC, Johnstone AC. Myelofibrosis in the dog: three case reports. J Small Anim Pract 1983;24:589-601.
50. Bunch SE, Easly JR, Cullen JM. Hematologic values and plasma and tissue folate concentrations in dogs given phenytoin on a long-term basis. Am J Vet Res 1990;51:1865-1868.
51. Atwell RB, Thornton JR, Odlum J. Suspected drug-induced thrombocytopenia associated with levamisole therapy in a dog. Aust Vet J 1981;57:91-93.
52. Atwell RB, Johnstone I, Read R, et al. Haemolytic anaemia in two dogs suspected to have been induced by levamisole. Aust Vet J 1979;55:292-294.
53. Stokol T, Randolph JF, Nachbar S, et al. Development of bone marrow toxicosis after albendazole administration in a dog and cat. J Am Vet Med Assoc 1997;210:1753-1756. (Pubitemid 27348676)
54. Watson ADJ. Bone marrow failure in a dog. J Small Anim Pract 1979;20:681-690. (Pubitemid 10166435)
55. Calvert CA, Sammarco C, Pickus C. Positive Coombs' test results in two dogs treated with amiodarone. J Am Vet Med Assoc 2000;216:1933-1936.
56. Jacobs G, Calvery C, Kraus M. Hepatopathy in 4 dogs treated with amiodarone. J Vet Intern Med 2000;14:96-99.
57. Holland M, Stobie D, Shapiro W. Pancytopenia associated with administration of captopril to a dog. J Am Vet Med Assoc 1996;208:1683-1686.
58. Randolph JF, Scarlett J, Stokol T, et al. Clinical efficacy and safety of recombinant canine erythropoietin in dogs with anemia of chronic renal failure and dogs with recombinant human erythropoietin-induced red cell aplasia. J Vet Intern Med 2004;18:81-91. (Pubitemid 38167821)
59. Cowgill LD, James KM, Levy JK, et al. Use of recombinant human erythropoietin for the management of anemia in dogs and cats with renal failure. J Am Vet Med Assoc 1998;212:521-528. (Pubitemid 28231709)
60. Handagama P, Feldman BF. Thrombocytopenia and drugs. Vet Clin North Am Small Anim Pract 1988;18:51-65. (Pubitemid 18056972)
61. Duncan SG, Meyers KM, Reed SM. Reduction of the red cell mass of the horse: toxic effect of heparin anticoagulant therapy. Am J Vet Res 1983;44:2272-2278.